NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced today that our ...
Submissions are supported by data from the Phase 3 Viti-Up clinical studies demonstrating upadacitinib achieved the co-primary endpoints of at least a 50% improvement ...
New data reveals that Montana is among the top states in the nation for protecting infants from Respiratory Syncytial Virus ...
News-Medical.Net on MSN
Herpes virus infection softens cell nuclei through internal mechanical changes
A recent international research project has used advanced microscopy techniques and computational modeling to discover why ...
We go to school, study further, then learn new things in our chosen careers. But no matter how much knowledge we acquire, ...
April 10, 2026 Target Action Date for RP1 in Advanced MelanomaWOBURN, Mass., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering ...
The health trial by researchers at the University of Southern Denmark has been suspended by Bissau-Guinean authorities.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results